Freestone Capital Holdings’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$902K Buy
19,488
+3,855
+25% +$178K 0.03% 230
2025
Q1
$953K Sell
15,633
-32,331
-67% -$1.97M 0.04% 216
2024
Q4
$2.71M Sell
47,964
-30,906
-39% -$1.75M 0.09% 138
2024
Q3
$4.08M Buy
78,870
+31,738
+67% +$1.64M 0.14% 110
2024
Q2
$1.96M Sell
47,132
-9,454
-17% -$393K 0.07% 163
2024
Q1
$3.07M Sell
56,586
-4,767
-8% -$259K 0.11% 127
2023
Q4
$3.15M Sell
61,353
-5,188
-8% -$266K 0.14% 114
2023
Q3
$3.86M Buy
66,541
+2,209
+3% +$128K 0.2% 83
2023
Q2
$4.11M Buy
64,332
+307
+0.5% +$19.6K 0.17% 89
2023
Q1
$4.44M Sell
64,025
-2,877
-4% -$199K 0.2% 79
2022
Q4
$4.81M Sell
66,902
-17,047
-20% -$1.23M 0.22% 74
2022
Q3
$5.97M Sell
83,949
-17,221
-17% -$1.22M 0.27% 61
2022
Q2
$7.79M Sell
101,170
-19,017
-16% -$1.46M 0.3% 52
2022
Q1
$8.78M Sell
120,187
-1,821
-1% -$133K 0.35% 61
2021
Q4
$7.61M Buy
122,008
+1,460
+1% +$91K 0.32% 68
2021
Q3
$7.13M Buy
120,548
+1,575
+1% +$93.2K 0.36% 63
2021
Q2
$7.95M Sell
118,973
-25,059
-17% -$1.67M 0.4% 59
2021
Q1
$9.09M Sell
144,032
-1,817
-1% -$115K 0.49% 46
2020
Q4
$9.05M Buy
145,849
+17,245
+13% +$1.07M 0.53% 37
2020
Q3
$7.75M Buy
128,604
+591
+0.5% +$35.6K 0.51% 41
2020
Q2
$7.53K Buy
128,013
+8,213
+7% +$483 0.09% 48
2020
Q1
$6.68K Sell
119,800
-5,132
-4% -$286 0.14% 50
2019
Q4
$8.02K Sell
124,932
-16,835
-12% -$1.08K 0.17% 40
2019
Q3
$7.19K Buy
141,767
+31,948
+29% +$1.62K 0.17% 47
2019
Q2
$4.98K Buy
+109,819
New +$4.98K 0.13% 106
2018
Q1
Sell
-3,463
Closed -$212K 331
2017
Q4
$212K Sell
3,463
-238
-6% -$14.6K 0.01% 319
2017
Q3
$236K Buy
+3,701
New +$236K 0.02% 304